International safety notice
ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2).
Brazil / Anvisa · BRA · Nov 26, 2015
Key facts
| Title | ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2). |
|---|---|
| Regulator | Brazil / Anvisa |
| Country | BRA |
| Brand | ADVIA Centaur HIV Ag/Ab Combo Assay (CHIV), registration 10345161863, risk class IV, Lots: 73544070 ;75980070 ;76675070 ;78024070 ;79139070. |
| Manufacturer | DETENTORA DO REGISTRO NO BRASIL SIEMENS HEALTHCARE DIAGNÓSTICOS SA CNPJ 01449930000190 ENDEREÇO AV MUTINGA 3800 7º ANDAR PIRITUBA SÃO PAULO SP FABRICANTE SIEMENS HEALTHCARE DIAGNOSTICS INC ENDEREÇO 511 BENEDICT AVENUE TARRYTOWN NY 1059415097 |
| Models | 76675070, 78024070, 75980070, 73544070, 79139070, 10345161863 |
| Date | Nov 26, 2015 |
| Regulator page | anvisa.gov.br |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1